Skin cancer risk among solid organ recipients: A nationwide cohort study in Denmark

Acta Dermato-Venereologica

Volumn 90, Issue 5, 2010, Pages 474-479

  Jensen, Annette Østergaard ^a   Sværke, Claus ^a   Farkas, Dora ^a   Pedersen, Lars ^a   Kragballe, Knud ^a   Sørensen, Henrik Toft ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Epidemiology; Organ transplantation; Skin cancer; Standardized incidence ratio

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CARDIAC GRAFT REJECTION; CHILD; COHORT ANALYSIS; DENMARK; DRUG BLOOD LEVEL; DRUG MEGADOSE; FEMALE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SKIN CANCER; SQUAMOUS CELL CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; COHORT STUDIES; DENMARK; FEMALE; HEART DISEASES; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFANT; INFANT, NEWBORN; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LIVER DISEASES; LIVER TRANSPLANTATION; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MELANOMA; MIDDLE AGED; ORGAN TRANSPLANTATION; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SKIN NEOPLASMS; YOUNG ADULT;

EID: 77957660824     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0919     Document Type: Article

References (29)

1. Harringer W, Haverich A. Heart and heart-lung transplantation: standards and improvements. World J Surg 2002; 26: 218-225. (Pubitemid 36920435)
2. Hoover R, Fraumeni JF Jr. Risk of cancer in renal-transplant recipients. Lancet 1973; 2: 55-57.
3. Kinlen LJ, Sheil AG, Peto J, Doll R. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J 1979; 2: 1461-1466.
4. Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohme I, Forsberg B, et al. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer 1995; 60: 183-189.
5. Birkeland SA, Lokkegaard H, Storm, HH. Cancer risk in patients on dialysis and after renal transplantation. Lancet 2000; 355: 1886-1887.
6. Bouwes Bavinck JN, Hardie DR, Green A, Cutmore S, MacNaught A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996; 61: 715-721.
7. Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 1990; 49: 506-509. (Pubitemid 20110465)
8. Jensen P, Hansen S, Moller B, Leivestad T, Pfeffer P, Geiran O, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40: 177-186. (Pubitemid 29072794)
9. Ong CS, Keogh AM, Kossard S, Macdonald PS, Spratt PM. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999; 40: 27-34. (Pubitemid 29051021)
10. Veness MJ, Quinn DI, Ong CS, Keogh AM, Macdonald PS, Cooper SG, et al. Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience. Cancer 1999; 85: 1758-1764.
11. Adami J, Gabel H, Lindelöf B, Ekström K, Rydh B, Glimelius B, et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003; 89: 1221-1227. (Pubitemid 37363407)
12. Lindelöf B, Sigurgeirsson B, Gabel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143: 513-519.
13. Kuijken I, Bouwes Bavinck JN. Skin cancer risk associated with immunosuppressive therapy in organ transplant recipients: epidemiology and proposed mechanisms. BioDrugs 2000; 14: 319-329.
14. Frank L. Epidemiology. When an entire country is a cohort. Science 2000; 287: 2398-2399.
15. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen, JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263-268.
16. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry - history, content, quality and use. Dan Med Bull 1997; 44: 535-539.
17. World Health Organization, International Association of Cancer Registries, Lyon, France at website: http://www.who.int/classifications/icd/ adaptations/oncology/en/.
18. Pallesen L, Kofod T, Kirkegaard P, Mortensen SA. Odontogen fokussanering forud for organ transplantation. Tandlægebladet 2008; 112: 518-527.
19. Breslow, NE, Day NE. Statistical methods in cancer research. Volume II - the design and analysis of cohort studies. IARC Sci Publ 1987; 1-406.
20. Meier P, Dayer E, Blanc E, Wauters JP. Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 204-212.
21. Marcil I, Stern RS. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study. Lancet 2001; 358: 1042-1045. (Pubitemid 32925124)
22. Glover MT, Deeks JJ, Raftery MJ, Cunningham J, Leigh IM. Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients. Lancet 1997; 349: 398. (Pubitemid 27077671)
23. Hojo M, Morimoto T, Maluccio M, Asano T, Morimoto K, Lagman M, et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999; 397: 530-534.
24. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905-913. (Pubitemid 38745589)
25. Kauffman HM, Cherikh WS, McBride MA, Cheng Y, Hanto DW. Post-transplant de novo malignancies in renal transplant recipients: the past and present. Transpl Int 2006; 19: 607-620.
26. Terhorst D, Drecoll U, Stockfleth E, Ulrich C. Organ transplant recipients and skin cancer: assessment of risk factors with focus on sun exposure. Br J Dermatol 2009; 161 Suppl 3: 85-89.
27. O'Donovan P, Perrett CM, Zhang X, Montaner B, Xu YZ, Harwood CA, et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005; 309: 1871-1874. (Pubitemid 41325100)
28. Klinger M, Mazanowska O. Primary idiopathic glomerulonephritis: modern algorithm for diagnosis and treatment. Pol Arch Med Wewn 2008; 118: 567-571.
29. Rothman KJ. Epidemiology: an introduction. New York: Oxford University Press, 2002.